Navigation Links
ULURU Inc. Reports First Quarter 2009 Financial Results
Date:5/15/2009

ADDISON, Texas, May 15 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE AMEX: ULU) today announced its financial results for the first quarter ended March 31, 2009. The Company reported a net loss of $3.1 million, or $0.05 per share, compared with a net loss of $1.8 million, or $0.03 per share, for the same period last year. At March 31, 2009, the Company held cash and cash equivalents of $5.1 million, compared with $7.6 million at December 31, 2009.

Commenting on the financial results Renaat Van den Hooff, President and CEO stated, "The increase in operating expenses continues to be driven by costs associated with our sales and marketing efforts for Altrazeal(TM) and the regulatory and clinical development costs of Altrazeal(TM) Silver and Altrazeal(TM) Collagen." Our recent accomplishments related to the Altrazeal(TM) wound care portfolio include:

  • The first published article on Altrazeal(TM) in human use appeared in "International Wound Journal," a peer-reviewed publication (Press release May 5, 2009)
  • There were 3 oral presentations and 20 posters published during the first four months of 2009 at several major Wound Care Conferences (DFCon, APWCA, and SAWC).
  • We obtained a temporary reimbursement (HCPCS) code for Altrazeal(TM).

Mr. Van den Hooff continued, "Despite the great clinical results we have experienced, we recognize that the selling cycle is taking longer than we originally expected. This has led us to refocus our sales strategy on specific sites of care. In parallel we have implemented cost improvement measures, including headcount reductions, in order to reduce our operating expenses moving forward. We are also continuing in our efforts to complete the acquisition of York Pharma plc. The
'/>"/>

SOURCE ULURU Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2009 and to Provide a Business Update
2. ULURU Inc. Announces Altrazeal(TM) Clinical Experience Published in the International Wound Journal
3. ULURU Inc. Signs Offer Letter to Acquire York Pharma plc
4. ULURU Inc. (ULURU) Dealing Disclosure Requirements
5. ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2008
6. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2008 and to Provide a Business Update
7. ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board
8. ULURU Inc. Announces Senior Management Change
9. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2008 and to Provide a Business Update
10. ULURU Inc. Announces the Launch of the Altrazeal(TM) Website
11. ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... May 03, 2015 “ BolehVPN ” was ... which features the latest and coolest technology products available to ... NewsWatch, conducted the review and shared with viewers how to ... does these days is on computers and even more so ... and meet people all over the world. In terms of ...
(Date:5/3/2015)... It is not too late to register to take part ... Lissa Anne Been in Arnold, Missouri on May 9, 2015. ... honor her loving memory. It has benefited the renowned Brain Aneurysm ... 37, Lissa suffered a brain aneurysm . After two operations ... event is designed to serve as a remembrance of her and ...
(Date:5/2/2015)... 02, 2015 Vancouver fencing company, QS Fencing, ... valuable advice to prospective clients related to their questions on ... install railings around their decks and patios. While that seems ... pop up once the person rolls up their sleeve to ... a railing in finding a gate that matches it. , ...
(Date:5/2/2015)... Delray Beach, FL (PRWEB) May 02, 2015 ... newspaper has selected The Delray Recovery Center as one ... Recovery Center is known in the addiction treatment field ... encourages staff members to innovate and to continue their ... promoting a positive workplace environment, never forgetting their purpose ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 As ... laxity issues of the face, neck and décolleté, ... concept with real potential for the success of ... the ThermiHealth Clinical Advisory Council, ThermiGyn’s Women’s Health ... FACS, ACGE, concluded that ThermiGyn’s temperature controlled radio ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3
... was first reported in the Luanda province of Angola on ... cholera// and 22 cholera related deaths have been reported in ... published by the World Health Organization, 101 new cholera and ... 24 hours. 8 municipalities have been reported to be affected ...
... children suffer from atopic eczema, a disease which causes the ... for new ways// to develop useful and powerful drug so ... eczema. ,Azathioprine is a drug that was developed ... their new organ. Its mechanism of action is by suppressing ...
... Nurses will now work for birth control in all the ... incidence of teenage pregnancies//. ,There are currently 2,409 nurses ... but the latest announcement signals a massive extension, reported the ... primary care trust will be funded to have at least ...
... new low nicotine Quest? cigarettes seems to have lulled ... a study conducted by researchers// at the Transdisciplinary Tobacco ... of Medicine.Results of the study have been published in ... author of this study, Caryn Lerman, PhD, Associate Director ...
... by the New England Research Institutes in collaboration with Yale ... too little// are at a greater risk of developing type ... on studies done on over 1709 men, in the age ... period of 15 yrs. ,According to the lead ...
... treatment of tuberculosis in the state would be achieved ... care sectors and NGOs, said health minister R Ashok, ... of the International TB day celebrations. ,The ... National Tuberculosis Control Programme (RNTCP) as being responsible for ...
Cached Medicine News:
(Date:5/1/2015)...   Heska Corporation (NASDAQ: HSKA - ... advanced veterinary diagnostic and other specialty veterinary products , ... present at the 16th Annual B. Riley & Co. Investor ... conference will be held May 12-14, 2015 at Lowes Hollywood ... will be available during the day on May 13 for ...
(Date:5/1/2015)... , May 1, 2015 ... expanded its current therapeutic focus beyond addiction ... serious psychiatric disorders. Braeburn has acquired an ... second-generation) antipsychotic risperidone for treatment of schizophrenia ... Braeburn acquires global rights to other potential ...
(Date:5/1/2015)... May 1, 2015  Boston Scientific Corporation (NYSE: ... business momentum and long-term growth strategies at a meeting ... York City . President and Chief Executive Officer ... the company has to bring forward meaningful innovation to ... and deliver shareholder value. "We are ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 2Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 3Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 4Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 5Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 6Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day 7
... NASHVILLE, Tenn., May 4, 2011 Cumberland Pharmaceuticals Inc. ... focused on hospital acute care and gastroenterology markets, today announced ...   For the three months ended March 31, 2011, net ... corresponding period in 2010. Revenue grew year-over-year despite a brief, ...
... May 4, 2011The U.S. Food and Drug Administration ... manufacture, market, or distribute over-the-counter (OTC) liquid drug ... to measure and dispense the doses of medication. ... The guidance, titled Dosage Delivery Devices for ...
Cached Medicine Technology:Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 2Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 3Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 4Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 5Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 6Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 7Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 8Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 9Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results 10FDA Issues Final Guidance for Liquid OTC Drug Products With Dispensing Devices 2FDA Issues Final Guidance for Liquid OTC Drug Products With Dispensing Devices 3
... System is a single-use, disposable needle loading ... into a Bard BrachyStar needle for interstitial ... radiation safety shield, inner compartment that holds ... fitting that connects the cartridge to the ...
... Holter Monitoring System uses technology developed by ... first true 12-lead digital Holter recorder in ... beat contained in the 24-hour study provides ... work done by the Q-12 digital recorder ...
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
... any clinical setting, offering an exclusive ... procedure. Customize Delphis™ to your exact ... Pocket PC, a Touchpad PC Tablet ... technology allows you to focus on ...
Medicine Products: